EUVIMEDEUVIMED entdecken
Fallbericht

Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation

Ijeoma J Eche, Myrna Nahas, Elissa Dunn, Ifeoma M Eche, Kerry L O'Brien

Clinical Journal of Oncology Nursing · 01.10.2019 · 23 (5) · 509-513

DOI: 10.1188/19.cjon.509-513 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 01.10.2019. Verfasst von Ijeoma J Eche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center. Hauptthemen laut MEDLINE: Blood Transfusion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood TransfusionAdultEye DiseasesHematopoietic Stem Cell TransplantationHumansMaleNeoplasmsTransplantation, Autologous

Stichwörter der Autor:innen

adverse eventsocular reactionplatelet transfusionstem cell transplantation

Autor:innen und Institutionen

  • Beth Israel Deaconess Medical Center.

Zitieren

APA

Eche, I. J., Nahas, M., Dunn, E., Eche, I. M., & O'Brien, K. L. (2019). Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation. Clinical Journal of Oncology Nursing, 23(5), 509-513. https://doi.org/10.1188/19.cjon.509-513

Vancouver

Eche IJ, Nahas M, Dunn E, Eche IM, O'Brien KL. Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation. Clinical Journal of Oncology Nursing. 2019;23(5):509-513. doi:10.1188/19.cjon.509-513

BibTeX
@article{Eche2019,
  author = {Eche, Ijeoma J and Nahas, Myrna and Dunn, Elissa and Eche, Ifeoma M and O'Brien, Kerry L},
  title = {Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation},
  journal = {Clinical Journal of Oncology Nursing},
  year = {2019},
  volume = {23},
  number = {5},
  pages = {509--513},
  doi = {10.1188/19.cjon.509-513}
}
Kostenlos starten →